Your fact-checks will appear here
American medical device company
Neuralink — Elon Musk’s neurotechnology company — received U.S. FDA clearance to begin a first‑in‑human clinical study of its brain‑implant device in May 2023, not a full drug approval . Available sou...
Neuralink — the neurotechnology company founded by Elon Musk — has implanted brain–computer interfaces (BCIs in human patients and demonstrated that at least some recipients can control external devic...
The regulates implanted brain‑computer interfaces (iBCIs) as medical devices and applies established device pathways and device‑specific guidance to them, including a 2021 final guidance on implanted ...
Billionaires and established venture firms — including via , via , , and others — have been publicly reported as investors in brain‑computer interface (BCI) startups such as and competing firms, while...
A search of the reporting provided finds no peer‑reviewed clinical trial publications showing that Neuralink has tested its implant specifically for Alzheimer’s disease or dementia; Neuralink’s early ...
Neuralink has publicly announced and opened first-in-human trials focused on restoring motor function for people with paralysis, chiefly adults with quadriplegia from spinal cord injury or amyotrophic...
The FDA’s recent work on implanted brain‑computer interfaces (BCIs) centers not on a single test but on clinical outcome assessments (COAs) that demonstrate real-world cognitive benefit—patient‑report...